Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease

Published:2022-03-11 Issue:8 Volume:55 Page:894-907
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Zamani Mohammad¹²^ORCID,Alizadeh‐Tabari Shaghayegh²,Singh Siddharth³,Loomba Rohit⁴^ORCID

Affiliation:

1. Digestive Diseases Research Center Digestive Diseases Research Institute, Tehran University of Medical Sciences Tehran Iran

2. Student Research Committee Babol University of Medical Sciences Babol Iran

3. Division of Gastroenterology, and Division of Biomedical Informatics University of California San Diego La Jolla California USA

4. NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine University of California San Diego La Jolla California USA

Funder

National Center for Advancing Translational Sciences

National Heart, Lung, and Blood Institute

National Institute on Alcohol Abuse and Alcoholism

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16879

Reference69 articles.

1. Evidence-based clinical practice guidelines for inflammatory bowel disease

2. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis

3. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

4. Extraintestinal Manifestations of Inflammatory Bowel Disease

5. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine alleviates ulcerative colitis by inhibiting inflammation through targeting IRGM1;Phytomedicine;2024-10

2. Exploring the butyrate metabolism-related shared genes in metabolic associated steatohepatitis and ulcerative colitis;Scientific Reports;2024-07-10

3. A cross sectional study assessing steatotic liver disease in patients with systemic lupus erythematosus;Scientific Reports;2024-06-20

4. Long‐term risk of cardiovascular disease associated with MASLD and different cardiometabolic risk factors in IBD patients: A prospective cohort study;Liver International;2024-05-31

5. Exploring shared molecular signatures and regulatory mechanisms in nonalcoholic steatohepatitis and inflammatory bowel disease using integrative bioinformatics analysis;Scientific Reports;2024-05-27